This $28 App Does What Your Office Scanner Never Could

If your workflow still relies on scattered scanning apps or aging office hardware, this deal on a lifetime subscription to ...

FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences Approval ...